What would have to be true about a company before you agreed to help other people bet against it? That question sits underneath one of the friendlier offers a brokerage can put in front of you, and it almost never gets asked out loud. A listener has a concentrated position in a name that gets shorted heavily, and his brokerage is pitching him their fully paid lending program. He can earn a little extra on shares he already owns and has no plans to sell. He wanted to know whether the deal is good on its own terms, and whether it does anything about the concentration itself. Those turn out to be two very different questions.
What You Are Actually Agreeing To
Short selling is the mirror image of buying a stock. A short seller borrows shares, sells them immediately at today’s price, and hopes to buy them back later at a lower one. Borrow at a hundred, sell at a hundred, buy back at eighty, keep the twenty.
Those borrowed shares have to come from somewhere, and in a fully paid lending program, they come from you. Your broker lends your shares out, collects a fee, and passes a portion along to you. The mechanics are legitimate and the money is real. The question is what the size of that payment tells you.
The Income Is Real, and It Is Small
How much you earn depends almost entirely on how badly someone wants to borrow what you own. Try to lend out a broad index fund like VOO or VTI and there simply is not much short interest to meet. On a $100,000 position you might collect somewhere around $50 a year. That is a rounding error.
Individual stocks are where it gets more interesting, because that is where short sellers concentrate. Someone who does not want to bet against the entire market but does want to bet against one specific company needs to borrow that specific company’s shares. A single-name concentrated position is exactly the kind of inventory that has demand behind it, so the payment might run to a few hundred dollars a year on $100,000 rather than fifty.
The Uncomfortable Logic of Getting Paid Well
Now follow that logic to the end. For this program to pay you meaningfully, there has to be a crowd of people who expect the stock to fall and are willing to pay for the privilege of betting on it. You are effectively saying you are glad to own a stock that lots of sophisticated people are wagering against, because it lets you collect a fee while they do it.
That should raise a flag rather than settle one. Heavy short interest is information about the position you hold, and the fee is that information arriving with a small check attached. Taking the check without reading the message is the part I would slow down on.
What You Give Up in the Tax Column
There is a second cost that is easy to miss. If your stock pays dividends, those dividends are most likely qualified, which means they are taxed at long-term capital gains rates. Once your shares are on loan, the borrower owes you the economic value of those dividends, but what you receive is a substitute payment rather than an actual dividend. Substitute payments are taxed as ordinary income.
Depending on your bracket, that swap alone can eat a real share of what the lending program pays you. You also give up voting rights while the shares are out on loan, which for most individual holders is not much of a sacrifice, but it belongs on the list.
If You Are Determined to Keep the Shares
None of this touches the concentration risk, which is the part that actually matters. The argument that a small stream of lending income offsets some of the downside is technically true and practically irrelevant. If the position falls thirty percent, a few hundred dollars of lending income is not a cushion.
If concentration is what is really driving the conversation, the honest answer is to address the concentration directly rather than to look for small income around the edges of it. If you have decided you are keeping the shares regardless, there are better tools. Selling covered calls above the market generates income at a scale that at least starts to matter. Add puts below the market, funded by those call premiums, and you have a collar that brackets how far the position can move in either direction. Both approaches add complexity and both deserve a real conversation with us, your advisors, before you put them on. But they are actually sized to the problem.
Small Yield, Wrong Problem
The lending program is not a scam and it is not going to hurt you. It is just answering a much smaller question than the one you have. A few hundred dollars a year, taxed less favorably than the dividends it replaces, does not change the risk profile of a position that dominates your portfolio. If the appeal of the program is that it feels like doing something about the concentration without having to sell anything, that is worth naming. The concentration is the thing to solve, and there is no version of lending your shares out that solves it.
This post is adapted from a recent episode of the Scholar Wealth Podcast. For more perspective on fully paid securities lending and concentrated stock positions, listen to the full podcast episode here.